Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

T1-Weighted Intensity Increase After a Single Administration of a Linear Gadolinium-Based Contrast Agent in Multiple Sclerosis.

Grahl S, Bussas M, Pongratz V, Kirschke JS, Zimmer C, Berthele A, Hemmer B, Mühlau M.

Clin Neuroradiol. 2020 Feb 13. doi: 10.1007/s00062-020-00882-6. [Epub ahead of print]

PMID:
32055874
2.

Prognostic value of white matter lesion shrinking in early multiple sclerosis: An intuitive or naïve notion?

Pongratz V, Schmidt P, Bussas M, Grahl S, Gaser C, Berthele A, Hoshi MM, Kirschke J, Zimmer C, Hemmer B, Mühlau M.

Brain Behav. 2019 Dec;9(12):e01417. doi: 10.1002/brb3.1417. Epub 2019 Sep 26.

3.

CSF parameters associated with early MRI activity in patients with MS.

Klein A, Selter RC, Hapfelmeier A, Berthele A, Müller-Myhsok B, Pongratz V, Gasperi C, Zimmer C, Mühlau M, Hemmer B.

Neurol Neuroimmunol Neuroinflamm. 2019 May 30;6(4):e573. doi: 10.1212/NXI.0000000000000573. eCollection 2019 Jul.

4.

CSF Protein Concentration Shows No Correlation With Brain Volume Measures.

Wuschek A, Grahl S, Pongratz V, Korn T, Kirschke J, Zimmer C, Hemmer B, Mühlau M.

Front Neurol. 2019 May 3;10:463. doi: 10.3389/fneur.2019.00463. eCollection 2019.

5.

Automated segmentation of changes in FLAIR-hyperintense white matter lesions in multiple sclerosis on serial magnetic resonance imaging.

Schmidt P, Pongratz V, Küster P, Meier D, Wuerfel J, Lukas C, Bellenberg B, Zipp F, Groppa S, Sämann PG, Weber F, Gaser C, Franke T, Bussas M, Kirschke J, Zimmer C, Hemmer B, Mühlau M.

Neuroimage Clin. 2019;23:101849. doi: 10.1016/j.nicl.2019.101849. Epub 2019 May 2.

6.

Accuracy of Unenhanced MRI in the Detection of New Brain Lesions in Multiple Sclerosis.

Eichinger P, Schön S, Pongratz V, Wiestler H, Zhang H, Bussas M, Hoshi MM, Kirschke J, Berthele A, Zimmer C, Hemmer B, Mühlau M, Wiestler B.

Radiology. 2019 May;291(2):429-435. doi: 10.1148/radiol.2019181568. Epub 2019 Mar 12.

PMID:
30860448
7.

Evidence for a white matter lesion size threshold to support the diagnosis of relapsing remitting multiple sclerosis.

Grahl S, Pongratz V, Schmidt P, Engl C, Bussas M, Radetz A, Gonzalez-Escamilla G, Groppa S, Zipp F, Lukas C, Kirschke J, Zimmer C, Hoshi M, Berthele A, Hemmer B, Mühlau M.

Mult Scler Relat Disord. 2019 Apr;29:124-129. doi: 10.1016/j.msard.2019.01.042. Epub 2019 Jan 28.

PMID:
30711877
8.

Geostatistical Analysis of White Matter Lesions in Multiple Sclerosis Identifies Gender Differences in Lesion Evolution.

Marschallinger R, Mühlau M, Pongratz V, Kirschke JS, Marschallinger S, Schmidt P, Sellner J.

Front Mol Neurosci. 2018 Dec 17;11:460. doi: 10.3389/fnmol.2018.00460. eCollection 2018.

9.

Predicting conversion from clinically isolated syndrome to multiple sclerosis-An imaging-based machine learning approach.

Zhang H, Alberts E, Pongratz V, Mühlau M, Zimmer C, Wiestler B, Eichinger P.

Neuroimage Clin. 2019;21:101593. doi: 10.1016/j.nicl.2018.11.003. Epub 2018 Nov 5.

10.

Interferon-beta specific T cells are associated with the development of neutralizing antibodies in interferon-beta treated multiple sclerosis patients.

Kalluri SR, Grummel V, Hracsko Z, Pongratz V, Pernpeintner V, Gasperi C, Buck D, Hemmer B; ABIRISK Consortium.

J Autoimmun. 2018 Mar;88:83-90. doi: 10.1016/j.jaut.2017.10.003. Epub 2017 Oct 21.

PMID:
29066027

Supplemental Content

Loading ...
Support Center